Quantcast

Madison Reporter

Monday, September 29, 2025

UW–Madison initiatives show statewide impact through research, healthcare programs

Webp aono2e5frkmwlemqf3nj740r27zh

Jennifer Mnookin Chancellor | Official website

Jennifer Mnookin Chancellor | Official website

A clinical trial at the University of Wisconsin–Madison is allowing kidney transplant patients to live without daily anti-rejection medication. This development could improve the quality of life for many patients who typically depend on these drugs after surgery.

The Wisconsin Idea Database, a project that tracks UW–Madison’s outreach, shows that the university has an impact across all 72 counties in Wisconsin. The data points to benefits in education, community engagement, health care, and workforce development throughout the state.

In another initiative addressing health care needs, Shane Hoffman is set to become the first graduate of an accelerated program at the UW School of Medicine and Public Health. The program aims to reduce training time for doctors planning to serve rural areas in Wisconsin.

A student recently chose UW–Madison over offers from 15 other top colleges. She cited "UW–Madison’s world-class reputation, the friendliness of the campus community and a financial aid offer she couldn’t refuse" as key factors in her decision.

ORGANIZATIONS IN THIS STORY

!RECEIVE ALERTS

The next time we write about any of these orgs, we’ll email you a link to the story. You may edit your settings or unsubscribe at any time.
Sign-up

DONATE

Help support the Metric Media Foundation's mission to restore community based news.
Donate